Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41.1M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
22.6M
-
Shares change
-
+15.2M
-
Total reported value, excl. options
-
$37.3M
-
Value change
-
+$25M
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$1.68
Significant Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q4 2024
15 filings reported holding ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock as of Q4 2024.
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.6M shares
of 41.1M outstanding shares and own 54.97% of the company stock.
Largest 10 shareholders include 22NW, LP (15.5M shares), Nantahala Capital Management, LLC (3.04M shares), MANGROVE PARTNERS IM, LLC (2.53M shares), LVW Advisors, LLC (633K shares), MORGAN STANLEY (420K shares), Ikarian Capital, LLC (158K shares), VANGUARD GROUP INC (154K shares), GEODE CAPITAL MANAGEMENT, LLC (91.3K shares), KING LUTHER CAPITAL MANAGEMENT CORP (59.7K shares), and BOOTHBAY FUND MANAGEMENT, LLC (18.8K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.